Akrevia Therapeutics

Akrevia Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted and combinable immuno-oncology therapeutics. Akrevia’s proprietary Aklusion™ platform technology allows natural and engineered biologics to be specifically activated in the tumor microenvironment, enabling dosing to full potency and expanding the universe of natural immune-activating proteins that can be safely delivered.

Headquarters Cambridge, MA
Website www.akrevia.com​
Pipeline Preclinical
Twitter @akrevia​
LinkedIn www.linkedin.com/company/akrevia/​